Teva to pay $225 mn to settle price fixing charges: DoJ, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The Israel-based drugmaker Teva Pharmaceuticals has agreed to pay a $225 million fine to settle price-fixing charges related to three of its medicines, the US Department of Justice (DoJ) said Monday. As part of the agreement, Teva agreed to divest from the widely used cholesterol drug pravastatin, which was at the heart of the “price-fixing conspiracy,” the DoJ said in a statement., The Israel-based drugmaker Teva Pharmaceuticals has agreed to pay a $225 million fine to settle price-fixing charges related to three of its medicines, the US Department of Justice (DoJ) said Monday. As part of the agreement, Teva agreed to divest from the widely used cholesterol drug pravastatin, which was at the heart of the “price-fixing conspiracy,” the DoJ said in a statement., , Read More